GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
HALOZYME THERAPEUTIC (HALO) [hlAlert]

Rating:
Buy HALO
up 273.49 %

HALOZYME THERAPEUTIC (HALO) rated Buy by Merriman Curhan Ford

Posted on: Thursday,  Feb 26, 2009  8:25 AM ET by Merriman Curhan Ford

Merriman Curhan Ford rated Buy HALOZYME THERAPEUTIC (NASDAQ: HALO) on 02/26/2009, when the stock price was $4.83. Since
then, HALOZYME THERAPEUTIC has gained 273.50% as of 08/27/2015's recent price of $18.04.
If you would have followed this Merriman Curhan Ford's recommendation on HALO, you would have gained 273.49% of your investment in 2373 days.

Halozyme Therapeutics, Inc. (Halozyme) is a biopharmaceutical company developing and commercializing products targeting the extracellular matrix (Matrix) for the endocrinology, oncology, dermatology and drug delivery markets The Company's products are based on the property covering the family of human enzymes known as hyaluronidases. The Company has two marketed products: HYLENEX, a product used as an adjuvant to increase the absorption and dispersion of other injected drugs and fluids, and Cumulase, a product used for in vitro fertilization (IVF). The Company has partnerships with F. Hoffmann-La Roche, Ltd and Hoffmann-La Roche, Inc. (Roche), to apply Enhanze Technology to Roche?s biological therapeutic compounds for up to 13 targets, and with Baxter Healthcare Corporation (Baxter), to apply Enhanze Technology to Baxter?s biological therapeutic compound, GAMMAGARD LIQUID.

We occupy a unique niche among our investment banking peers: we offer our clients both traditional sell-side equity research and primary market research, and we focus on high-potential sectors such as CleanTech, Consumer/Internet/Media, Health Care and Tech/Telecom. Our institutional and corporate clients get the best of both worlds: expertise from our analysts and access to experts through our Panel Intelligence platform.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/26/2009 8:25 AM Buy
None
4.83
as of 12/31/2009
1 Week up  13.60 %
1 Month up  30.03 %
3 Months down  -0.14 %
1 YTD up  46.99 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy